Contraceptive method | Overall (n=2542*) [n (%)] | Female (n=1622) [n (%)] | Male (n=920) [n (%)] | p |
---|---|---|---|---|
Dual method | 686 (27) | 498 (31) | 188 (20) | <0.0001 |
Highly effective method only* | 250 (10) | 210 (13) | 40 (4) | |
Condom only | 1332 (52) | 716 (44) | 616 (67) | |
No method | 274 (11) | 198 (12) | 76 (8) | |
Dual method use | ||||
Condom+pill | 117 (17) | 67 (13) | 50 (27) | <0.0001 |
Condom+injectable | 381 (56) | 303 (61) | 78 (41) | |
Condom+LAPM† | 134 (20) | 85 (17) | 49 (26) | |
Condom+multiple methods‡ | 54 (8) | 43 (9) | 11 (6) | |
Highly effective method | ||||
Pill | 57 (23) | 45 (21) | 12 (30) | 0.76 |
Injectable | 133 (53) | 113 (54) | 20 (50) | |
LAPM† | 40 (16) | 34 (16) | 6 (15) | |
Multiple methods‡ | 20 (8) | 18 (9) | 2 (5) | |
Unmet need for dual method | 1856 (73) | 1124 (69) | 732 (80) | <0.0001 |
N=3538 excluding those who desired a pregnancy (n=565); women aged >49 years (n=63); participants with missing data on contraceptive use (n=268); or missing data on pregnancy desire (n=100).
*Highly effective methods included hormonal methods (pill, injectable, implant), intrauterine device or permanent.
†LAPM, long-acting or permanent methods (implants, intrauterine device, tubal ligation, vasectomy).
‡Multiple highly effective methods reported.